Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)

Clinical Trial ID: NCT03620747


Learn about this trial.

Check the eligibility requirements, study details, and more.